Inhibition of eIF2α Phosphorylation Enhances the Sensitivity of Renal Cell Carcinoma Cells to Sorafenib-Induced Ferroptosis

Lihang Yu, Chuanchuan Zhan, Jiajun Yan, Ke Gao, Chong Shen, Yu Ren

PDF(4562 KB)
For Authors|For Editors|For Reviewers
PDF(4562 KB)
Discovery Medicine ›› 2025, Vol. 37 ›› Issue (203) : 2966-2977. DOI: 10.24976/Discov.Med.202537203.248
Article

Inhibition of eIF2α Phosphorylation Enhances the Sensitivity of Renal Cell Carcinoma Cells to Sorafenib-Induced Ferroptosis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 37(203): 2966-2977 https://doi.org/10.24976/Discov.Med.202537203.248

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(4562 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2025.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉